Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Checkmate Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Checkmate Pharmaceuticals, Inc.Listing unverified | Buy | $2M | conv 46ClusterFirst in 12mo | SEC | |
Checkmate Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Iterum Therapeutics plcListing unverified | Sell | $169K | SEC | ||
Iterum Therapeutics plcListing unverified | Sell | $644K | SEC | ||
NextCure, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
NextCure, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
NextCure, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
NextCure, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
NextCure, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
NextCure, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
NextCure, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
NextCure, Inc.Listing on record | Buy | $6M | conv 49ClusterFirst in 12mo | SEC | |
NextCure, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |